628 related articles for article (PubMed ID: 26693397)
21. Cervical Cord T1-weighted Hypointense Lesions at MR Imaging in Multiple Sclerosis: Relationship to Cord Atrophy and Disability.
Valsasina P; Aboulwafa M; Preziosa P; Messina R; Falini A; Comi G; Filippi M; Rocca MA
Radiology; 2018 Jul; 288(1):234-244. PubMed ID: 29664341
[TBL] [Abstract][Full Text] [Related]
22. Multiple sclerosis: hyperintense lesions in the brain on T1-weighted MR images assessed by diffusion tensor imaging.
Zhou F; Shiroishi M; Gong H; Zee CS
J Magn Reson Imaging; 2010 Apr; 31(4):789-95. PubMed ID: 20373421
[TBL] [Abstract][Full Text] [Related]
23. CEST 2022 - Differences in APT-weighted signal in T1 weighted isointense lesions, black holes and normal-appearing white matter in people with relapsing-remitting multiple sclerosis.
Khormi I; Al-Iedani O; Casagranda S; Papageorgakis C; Alshehri A; Lea R; Liebig P; Ramadan S; Lechner-Scott J
Magn Reson Imaging; 2023 Oct; 102():212-221. PubMed ID: 37321380
[TBL] [Abstract][Full Text] [Related]
24. PREVAIL: Predicting Recovery through Estimation and Visualization of Active and Incident Lesions.
Dworkin JD; Sweeney EM; Schindler MK; Chahin S; Reich DS; Shinohara RT
Neuroimage Clin; 2016; 12():293-9. PubMed ID: 27551666
[TBL] [Abstract][Full Text] [Related]
25. A Multicenter Longitudinal MRI Study Assessing LeMan-PV Software Accuracy in the Detection of White Matter Lesions in Multiple Sclerosis Patients.
Todea AR; Melie-Garcia L; Barakovic M; Cagol A; Rahmanzadeh R; Galbusera R; Lu PJ; Weigel M; Ruberte E; Radue EW; Schaedelin S; Benkert P; Oezguer Y; Sinnecker T; Müller S; Achtnichts L; Vehoff J; Disanto G; Findling O; Chan A; Salmen A; Pot C; Lalive P; Bridel C; Zecca C; Derfuss T; Remonda L; Wagner F; Vargas M; Du Pasquier R; Pravata E; Weber J; Gobbi C; Leppert D; Wuerfel J; Kober T; Marechal B; Corredor-Jerez R; Psychogios M; Lieb J; Kappos L; Cuadra MB; Kuhle J; Granziera C;
J Magn Reson Imaging; 2023 Sep; 58(3):864-876. PubMed ID: 36708267
[TBL] [Abstract][Full Text] [Related]
26. Chronic white matter lesion activity predicts clinical progression in primary progressive multiple sclerosis.
Elliott C; Belachew S; Wolinsky JS; Hauser SL; Kappos L; Barkhof F; Bernasconi C; Fecker J; Model F; Wei W; Arnold DL
Brain; 2019 Sep; 142(9):2787-2799. PubMed ID: 31497864
[TBL] [Abstract][Full Text] [Related]
27. Progressive gray matter damage in patients with relapsing-remitting multiple sclerosis: a longitudinal diffusion tensor magnetic resonance imaging study.
Oreja-Guevara C; Rovaris M; Iannucci G; Valsasina P; Caputo D; Cavarretta R; Sormani MP; Ferrante P; Comi G; Filippi M
Arch Neurol; 2005 Apr; 62(4):578-84. PubMed ID: 15824256
[TBL] [Abstract][Full Text] [Related]
28. Increased cortical grey matter lesion detection in multiple sclerosis with 7 T MRI: a post-mortem verification study.
Kilsdonk ID; Jonkman LE; Klaver R; van Veluw SJ; Zwanenburg JJ; Kuijer JP; Pouwels PJ; Twisk JW; Wattjes MP; Luijten PR; Barkhof F; Geurts JJ
Brain; 2016 May; 139(Pt 5):1472-81. PubMed ID: 26956422
[TBL] [Abstract][Full Text] [Related]
29. Temporal evolution of acute multiple sclerosis lesions on serial sodium (
Eisele P; Konstandin S; Szabo K; Ebert A; Roßmanith C; Paschke N; Kerschensteiner M; Platten M; Schoenberg SO; Schad LR; Gass A
Mult Scler Relat Disord; 2019 Apr; 29():48-54. PubMed ID: 30669020
[TBL] [Abstract][Full Text] [Related]
30. Variations in T1 and T2 relaxation times of normal appearing white matter and lesions in multiple sclerosis.
Stevenson VL; Parker GJ; Barker GJ; Birnie K; Tofts PS; Miller DH; Thompson AJ
J Neurol Sci; 2000 Sep; 178(2):81-7. PubMed ID: 11018698
[TBL] [Abstract][Full Text] [Related]
31. Histopathology-validated recommendations for cortical lesion imaging in multiple sclerosis.
Bouman PM; Steenwijk MD; Pouwels PJW; Schoonheim MM; Barkhof F; Jonkman LE; Geurts JJG
Brain; 2020 Oct; 143(10):2988-2997. PubMed ID: 32889535
[TBL] [Abstract][Full Text] [Related]
32. Gradient echo magnetic resonance imaging correlates with clinical measures and allows visualization of veins within multiple sclerosis lesions.
Luo J; Yablonskiy DA; Hildebolt CF; Lancia S; Cross AH
Mult Scler; 2014 Mar; 20(3):349-55. PubMed ID: 23836876
[TBL] [Abstract][Full Text] [Related]
33. Deeply 3D-T1-TFE hypointense voxels are characteristic of phase-rim lesions in multiple sclerosis.
Naval-Baudin P; Pons-Escoda A; Camins À; Arroyo P; Viveros M; Castell J; Cos M; Martínez-Yélamos A; Martínez-Yélamos S; Majós C
Eur Radiol; 2024 Feb; 34(2):1337-1345. PubMed ID: 37278854
[TBL] [Abstract][Full Text] [Related]
34. Long-term evolution of multiple sclerosis iron rim lesions in 7 T MRI.
Dal-Bianco A; Grabner G; Kronnerwetter C; Weber M; Kornek B; Kasprian G; Berger T; Leutmezer F; Rommer PS; Trattnig S; Lassmann H; Hametner S
Brain; 2021 Apr; 144(3):833-847. PubMed ID: 33484118
[TBL] [Abstract][Full Text] [Related]
35. Use of ultrasmall superparamagnetic particles of iron oxide (USPIO)-enhanced MRI to demonstrate diffuse inflammation in the normal-appearing white matter (NAWM) of multiple sclerosis (MS) patients: an exploratory study.
Vellinga MM; Vrenken H; Hulst HE; Polman CH; Uitdehaag BM; Pouwels PJ; Barkhof F; Geurts JJ
J Magn Reson Imaging; 2009 Apr; 29(4):774-9. PubMed ID: 19306366
[TBL] [Abstract][Full Text] [Related]
36. T2 Relaxometry Evidence of Microstructural Changes in Diffusely Abnormal White Matter in Relapsing-Remitting Multiple Sclerosis and Clinically Isolated Syndrome: Impact on Visuomotor Performance.
Papadaki E; Mastorodemos V; Panou T; Pouli S; Spyridaki E; Kavroulakis E; Kalaitzakis G; Maris TG; Simos P
J Magn Reson Imaging; 2021 Oct; 54(4):1077-1087. PubMed ID: 33960066
[TBL] [Abstract][Full Text] [Related]
37. Brain and cord myelin water imaging: a progressive multiple sclerosis biomarker.
Kolind S; Seddigh A; Combes A; Russell-Schulz B; Tam R; Yogendrakumar V; Deoni S; Sibtain NA; Traboulsee A; Williams SC; Barker GJ; Brex PA
Neuroimage Clin; 2015; 9():574-80. PubMed ID: 26594633
[TBL] [Abstract][Full Text] [Related]
38. Tissue damage within normal appearing white matter in early multiple sclerosis: assessment by the ratio of T1- and T2-weighted MR image intensity.
Beer A; Biberacher V; Schmidt P; Righart R; Buck D; Berthele A; Kirschke J; Zimmer C; Hemmer B; Mühlau M
J Neurol; 2016 Aug; 263(8):1495-502. PubMed ID: 27178000
[TBL] [Abstract][Full Text] [Related]
39. Voxel-based assessment of differences in damage and distribution of white matter lesions between patients with primary progressive and relapsing-remitting multiple sclerosis.
Di Perri C; Battaglini M; Stromillo ML; Bartolozzi ML; Guidi L; Federico A; De Stefano N
Arch Neurol; 2008 Feb; 65(2):236-43. PubMed ID: 18268194
[TBL] [Abstract][Full Text] [Related]
40. Histogram analysis of quantitative T1 and MT maps from ultrahigh field MRI in clinically isolated syndrome and relapsing-remitting multiple sclerosis.
Al-Radaideh A; Mougin OE; Lim SY; Chou IJ; Constantinescu CS; Gowland P
NMR Biomed; 2015 Nov; 28(11):1374-82. PubMed ID: 26346925
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
